본문 바로가기
KERD
논문KCI 등재

Stem Cell Therapy for Neurogenic Bladder Dysfunction in Rodent Models: A Systematic Review

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Purpose: Neurogenic bladder dysfunction (NGB) has an impact on the quality of life, which made it an important research subject in preclinical studies. The present review investigates the effect of stem cell (SC) therapy on bladder functional recovery after the onset of spinal cord injury (SCI), multiple sclerosis (MS), Parkinson disease (PD), and stroke in rodent models. Methods: All experiments evaluated the regenerative potential of SC on the management of NGB in rodent models up to June 2019, were included. From 1,189 relevant publications, 20 studies met our inclusion criteria of which 15 were conducted on SCI, 2 on PD, 2 on stroke, and 1 on MS in the rodent models. We conducted a meta-analysis on SCI experiments and for other neurological diseases, detailed urodynamic findings were reported. Results: The common SC sources used for therapeutical purposes were neural progenitor cells, bone marrow mesenchymal SCs, human amniotic fluid SCs, and human umbilical cord blood SCs. There was a significant improvement of micturition pressure in both contusion and transaction SCI models 4 and 8 weeks post-SC transplantation. Residual urine volume, micturition volume, and bladder capacity were improved 28 days after SC transplantation only in the transaction model of SCI. Nonvoiding contraction recovered only in 56 days post-cell transplantation in the contusion model. Conclusions: Partial bladder recovery has been evident after SC therapy in SCI models. Due to limitations in the number of studies in other neurological diseases, additional studies are necessary to confirm the detailed mechanism for bladder recovery.

Abstract

Purpose: Neurogenic bladder dysfunction (NGB) has an impact on the quality of life, which made it an important research subject in preclinical studies. The present review investigates the effect of stem cell (SC) therapy on bladder functional recovery after the onset of spinal cord injury (SCI), multiple sclerosis (MS), Parkinson disease (PD), and stroke in rodent models. Methods: All experiments evaluated the regenerative potential of SC on the management of NGB in rodent models up to June 2019, were included. From 1,189 relevant publications, 20 studies met our inclusion criteria of which 15 were conducted on SCI, 2 on PD, 2 on stroke, and 1 on MS in the rodent models. We conducted a meta-analysis on SCI experiments and for other neurological diseases, detailed urodynamic findings were reported. Results: The common SC sources used for therapeutical purposes were neural progenitor cells, bone marrow mesenchymal SCs, human amniotic fluid SCs, and human umbilical cord blood SCs. There was a significant improvement of micturition pressure in both contusion and transaction SCI models 4 and 8 weeks post-SC transplantation. Residual urine volume, micturition volume, and bladder capacity were improved 28 days after SC transplantation only in the transaction model of SCI. Nonvoiding contraction recovered only in 56 days post-cell transplantation in the contusion model. Conclusions: Partial bladder recovery has been evident after SC therapy in SCI models. Due to limitations in the number of studies in other neurological diseases, additional studies are necessary to confirm the detailed mechanism for bladder recovery.

참고문헌 (87)

  1. Wein AJ, "Overactive bladder : a better understanding of pathophysiology, diagnosis and management", J Urol, 175, pp.S5~10 (2006)
  2. Dorsher PT, "Neurogenic bladder", Adv Urol, 2012, pp.816274~ (2012)
  3. Anderson KD, "Targeting recovery : priorities of the spinal cord-injured population", J Neurotrauma, 21, pp.1371~1383 (2004)
  4. Hajebrahimi S, "Management of neurogenic bladder in patients with Parkinson’s disease : a systematic review", Neurourol Urodyn, 38, pp.31~62 (2019)
  5. Hajebrahimi S, "Clinical and transperineal ultrasound findings in females with stress urinary incontinence versus normal controls", Pak J Biol Sci, 12, pp.1434~1437 (2009)
  6. Wyndaele JJ, "Conservative treatment of the neuropathic bladder in spinal cord injured patients", Spinal Cord, 39, pp.294~300 (2001)
  7. Gajewski JB, "An International Continence Society(ICS)report on the terminology for adult neurogenic lower urinary tract dysfunction(ANLUTD)", Neurourol Urodyn, 37, pp.1152~1161 (2018)
  8. de Sèze M, "The neurogenic bladder in multiple sclerosis : review of the literature and proposal of management guidelines", Mult Scler, 13, pp.915~928 (2007)
  9. Sauerwein D, "Die operative Behandlung der spastischen Blasenlähmung bei Querschnittlähmung. Sakrale Deafferentation (SDAF)mit der Implantation eines sakralen Vorderwurzelstimulators (SARS) Surgical treatment of spastic bladder paralysis in paraplegic patients. Sacral deafferentation with implantation of a sacral anterior root stimulator", Urologe A, 29, pp.196~203 (1990)
  10. Jahn P, "Types of indwelling urinary catheters for long-term bladder drainage in adults", Cochrane Database Syst Rev, 10, pp.CD004997~ (2012)
  11. Salehi-Pourmehr H, "Intra-bladder wall transplantation of bone marrow mesenchymal stem cells improved urinary bladder dysfunction following spinal cord injury", Life Sci, 221, pp.20~28 (2019)
  12. Azizi R, "Stem cell therapy in Asherman syndrome and thin endometrium : Stem cell-based therapy", Biomed Pharmacother, 102, pp.333~343 (2018)
  13. Negro A, "Stem cells and cancer stem cells, volume 3", pp.173~178 (2012), Springer
  14. Robey TE, "Systems approaches to preventing transplanted cell death in cardiac repair", J Mol Cell Cardiol, 45, pp.567~581 (2008)
  15. Sadigh-Eteghad S, "D-galactose-induced brain ageing model : a systematic review and meta-analysis on cognitive outcomes and oxidative stress indices", PLoS One, 12, pp.e0184122~ (2017)
  16. Amariglio N, "Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient", PLoS Med, 6, pp.e1000029~ (2009)
  17. Chen W, "Progress in dopaminergic cell replacement and regenerative strategies for Parkinson’s disease", ACS Chem Neurosci, 10, pp.839~851 (2019)
  18. Kim JH, "Bladder recovery by stem cell based cell therapy in the bladder dysfunction induced by spinal cord injury : systematic review and metaanalysis", PLoS One, 10, pp.e0113491~ (2015)
  19. Park WB, "The effect of mesenchymal stem cell transplantation on the recovery of bladder and hindlimb function after spinal cord contusion in rats", BMC Neurosci, 11, pp.119~ (2010)
  20. Cho YS, "Oral mucosa stem cells alleviates spinal cord injury-induced neurogenic bladder symptoms in rats", J Biomed Sci, 21, pp.43~ (2014)
  21. Fandel TM, "Transplanted human stem cell-derived interneuron precursors mitigate mouse bladder dysfunction and central neuropathic pain after spinal cord injury", Cell Stem Cell, 19, pp.544~557 (2016)
  22. Jin Y, "Transplantation of neural progenitor cells in chronic spinal cord injury", Neuroscience, 320, pp.69~82 (2016)
  23. Campeau L, "Effects of allogeneic bone marrow derived mesenchymal stromal cell therapy on voiding function in a rat model of Parkinson disease", J Urol, 191, pp.850~859 (2014)
  24. Soler R, "Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease", J Urol, 187, pp.1491~1497 (2012)
  25. Liang CC, "Effect of umbilical cord blood stem cells transplantation on bladder dysfunction induced by cerebral ischemia in rats", Taiwan J Obstet Gynecol, 55, pp.672~679 (2016)
  26. Liang CC, "Bladder transplantation of amniotic fluid stem cell may ameliorate bladder dysfunction after focal cerebral ischemia in rat", Stem Cells Transl Med, 6, pp.1227~1236 (2017)
  27. Jin Z, "Involvement of interstitial cells of Cajal in bladder dysfunction in mice with experimental autoimmune encephalomyelitis", Int Urol Nephrol, 49, pp.1353~1359 (2017)
  28. Neuhuber B, "Stem cell delivery by lumbar puncture as a therapeutic alternative to direct injection into injured spinal cord", J Neurosurg Spine, 9, pp.390~399 (2008)
  29. Temeltas G, "Bladder function recovery in rats with traumatic spinal cord injury after transplantation of neuronal-glial restricted precursors or bone marrow stromal cells", J Urol, 181, pp.2774~2779 (2009)
  30. Jin Y, "Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury", J Neurotrauma, 28, pp.579~594 (2011)
  31. Mitsui T, "Immortalized neural stem cells transplanted into the injured spinal cord promote recovery of voiding function in the rat", J Urol, 170, pp.1421~1425 (2003)
  32. Mitsui T, "Acute administration of AMPA", Kainate blocker combined with delayed transplantation of neural precursors improves lower urinary tract function in spinal injured rats, 2011, pp.1418, 23~31
  33. Mitsui T, "Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry", J Neurosci, 25, pp.9624~9636 (2005)
  34. Sandner B, "Limited functional effects of subacute syngeneic bone marrow stromal cell transplantation after rat spinal cord contusion injury", Cell Transplant, 25, pp.125~139 (2016)
  35. Bugos O, "Beyond the rat models of human neurodegenerative disorders", Cell Mol Neurobiol, 29, pp.859~869 (2009)
  36. Wein AJ, "Campbell-Walsh urology: expert consult premium edition: enhanced online features and print, 4-volume set" (2011), Elsevier Health Sciences
  37. Craggs MD, "Aberrant reflexes and function of the pelvic organs following spinal cord injury in man", Auton Neurosci, 126-127, pp.355~370 (2006)
  38. Vizzard MA, "Alterations in growth-associated protein(GAP-43)expression in lower urinary tract pathways following chronic spinal cord injury", Somatosens Mot Res, 16, pp.369~381 (1999)
  39. Birder LA, "Role of the urothelium in urinary bladder dysfunction following spinal cord injury", Prog Brain Res, 152, pp.135~146 (2006)
  40. Apodaca G, "Disruption of bladder epithelium barrier function after spinal cord injury", Am J Physiol Renal Physiol, 284, pp.F966~F976 (2003)
  41. Fowler CJ, "Neurological disorders of micturition and their treatment", Brain, 122, pp.1213~1231 (1999)
  42. Fowler CJ, "The neural control of micturition", Nat Rev Neurosci, 9, pp.453~466 (2008)
  43. Lee TH, "Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats", Stroke, 1998, pp.1687~1696 (1998)
  44. Yokoyama O, "Forebrain muscarinic control of micturition reflex in rats", Neuropharmacology, 41, pp.629~638 (2001)
  45. Yokoyama O, "Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion", Am J Physiol, 276, pp.R935~R942 (1999)
  46. Yokoyama O, "Role of the forebrain in bladder overactivity following cerebral infarction in the rat", Exp Neurol, 163, pp.469~476 (2000)
  47. Ochodnický P, "Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target", Neurourol Urodyn, 30, pp.1227~1241 (2011)
  48. Yamanishi T, "Role of urodynamic studies in the diagnosis and treatment of lower urinary tract symptoms", Urol Sci, 22, pp.120~128 (2011)
  49. Sakakibara R, "Micturitional disturbance and the pontine tegmental lesion : urodynamic and MRI analyses of vascular cases", J Neurol Sci, 141, pp.105~110 (1996)
  50. Sakakibara R, "Pathophysiology of bladder dysfunction in Parkinson’s disease", Neurobiol Dis, 46, pp.565~571 (2012)
  51. Yoshimura N, "The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)", Neuropharmacology, 32, pp.315~321 (1993)
  52. Campeau L, "1070 Rat bone marrow derived mesenchymal stem cell therapy in a Parkinsonian animal model of detrusor overactivity", Eur Urol Suppl, 11, pp.e1070~ (2012)
  53. Seki S, "Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats", Neurourol Urodyn, 20, pp.105~113 (2001)
  54. Hattori T, "Voiding dysfunction in Parkinson’s disease", Jpn J Psychiatry Neurol, 46, pp.181~186 (1992)
  55. Sakakibara R, "Bowel and bladder disorders in Parkinson’s disease", Nihon Rinsho, 75, pp.111~118 (2017)
  56. Traugott U, "Chronic relapsing experimental allergic encephalomyelitis. Correlation of circulating lymphocyte fluctuations with disease activity in suppressed and unsuppressed animals", J Neurol Sci, 41, pp.17~29 (1979)
  57. McCarthy DP, "Mouse models of multiple sclerosis : experimental autoimmune encephalomyelitis and Theiler’s virus-induced demyelinating disease", Methods Mol Biol, 900, pp.381~401 (2012)
  58. Terry RL, "Experimental autoimmune encephalomyelitis in mice", Methods Mol Biol, 1304, pp.145~160 (2016)
  59. Negoro H, "Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model", Sci Rep, 3, pp.2152~ (2013)
  60. Oppenheimer DR, "The cervical cord in multiple sclerosis", Neuropathol Appl Neurobiol, 4, pp.151~162 (1978)
  61. Corcos J, "A urological challenge : voiding dysfunction in multiple sclerosis", Can Urol Assoc J, 7, pp.S181~2 (2013)
  62. 유구한, "Experimental Animal Models of Neurogenic Bladder Dysfunction", International Neurourology Journal, 14(1), pp.1~6 (2010), 대한배뇨장애요실금학회
  63. Abolhasanpour N, "Urodynamic parameters in spinal cord injury-induced neurogenic bladder rats after stem cell transplantation : a narrative review", Iran J Med Sci, 45, pp.2~15 (2020)
  64. Yamanishi T, "The nature of detrusor bladder neck dyssynergia in non-neurogenic bladder dysfunction", J Auton Nerv Syst, 66, pp.163~168 (1997)
  65. Blaivas JG, "Detrusor-external sphincter dyssynergia : a detailed electromyographic study", J Urol, 125, pp.545~548 (1981)
  66. Yoshiyama M, "Changes in micturition after spinal cord injury in conscious rats", Urology, 54, pp.929~933 (1999)
  67. Nagatomi J, "Changes in the biaxial viscoelastic response of the urinary bladder following spinal cord injury", Ann Biomed Eng, 32, pp.1409~1419 (2004)
  68. de Groat WC, "Neural control of the lower urinary tract", Compr Physiol, 5, pp.327~396 (2015)
  69. Panicker JN, "Lower urinary tract dysfunction in the neurological patient : clinical assessment and management", Lancet Neurol, 14, pp.720~732 (2015)
  70. Leventhal A, "The benefits and risks of stem cell technology", Oral Dis, 18, pp.217~222 (2012)
  71. Bonner JF, "Promoting directional axon growth from neural progenitors grafted into the injured spinal cord", J Neurosci Res, 88, pp.1182~1192 (2010)
  72. Mitsui T, "Transplants of fibroblasts expressing BDNF and NT-3 promote recovery of bladder and hindlimb function following spinal contusion injury in rats", Exp Neurol, 194, pp.410~431 (2005)
  73. Kim JH, "Stem cell therapy in bladder dysfunction : where are we? And where do we have to go", Biomed Res Int, 2013, pp.930713~ (2013)
  74. Lee HJ, "Improvement in spinal cord injury-induced bladder fibrosis using mesenchymal stem cell transplantation into the bladder wall", Cell Transplant, 24, pp.1253~1263 (2015)
  75. Ronaghi M, "Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?", Stem Cells, 28, pp.93~99 (2010)
  76. Orlandin JR, "Glial scar-modulation as therapeutic tool in spinal cord injury in animal models", Acta Cir Bras, 32, pp.168~174 (2017)
  77. Cruz CD, "Spinal cord injury and bladder dysfunction : new ideas about an old problem", ScientificWorldJournal, 11, pp.214~234 (2011)
  78. Chhabra HS, "Autologous bone marrow cell transplantation in acute spinal cord injury--an Indian pilot study", Spinal Cord, 54, pp.57~64 (2016)
  79. Cheng H, "Clinical observation of umbilical cord mesenchymal stem cell transplantation in treatment for sequelae of thoracolumbar spinal cord injury", J Transl Med, 12, pp.253~ (2014)
  80. Dai G, "Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury", Brain Res, 1533, pp.73~79 (2013)
  81. El-Kheir WA, "Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients", Cell Transplant, 23, pp.729~745 (2014)
  82. Xu P, "The efficacy and safety of mesenchymal stem cell transplantation for spinal cord injury patients : a meta-analysis and systematic review", Cell Transplant, 28, pp.36~46 (2019)
  83. Alexanian AR, "An efficient method for generation of neural-like cells from adult human bone marrow-derived mesenchymal stem cells", Regen Med, 5, pp.891~900 (2010)
  84. Moviglia GA, "Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients", Cytotherapy, 8, pp.202~209 (2006)
  85. Hu Y, "Intravenously transplanted bone marrow stromal cells promote recovery of lower urinary tract function in rats with complete spinal cord injury", Spinal Cord, 50, pp.202~207 (2012)
  86. Temeltas G, "Effects of neuronal and glial restricted precursor cells transplantation on erectile function after experimentally induced spinal cord injury", J Sex Med, 6, pp.3265~3273 (2009)
  87. DePaul MA, "Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury", Sci Rep, 5, pp.16795~ (2015)

관련 논문AI추천

이 간행물의 다른 논문 (14건)